MetaSight uses metabolomics, lipidomics and proteomics mass spectrometry technologies to develop tests for specific diseases, including conditions outside of oncology.

Researchers have built a blood-based “clock” that estimates when Alzheimer’s symptoms will likely begin, potentially years before any memory loss appears. The model, validated in two major ...

insights from industryJeff ZondermanSenior Vice PresidentBruker Applied Mass Spectrometry In this interview, AZoM speaks to Jeff Zonderman from Bruker Applied Mass Spectrometry about the future of ...

Phase 2 study evaluating efficacy and safety of everolimus with letrozole in advanced (unresectable or metastatic) non-small cell lung cancer (NSCLC) after failure of platinum-based treatment: A ...

If you have ever thought, “I wish I could have a mass spectrometer at home,” then we aren’t very surprised you are reading Hackaday. [Thomas Scherrer] somehow acquired a broken Brucker Microflex LT ...

After decades of nonstarters, blood tests for Alzheimer’s disease are finally here, enabling researchers to predict who may have amyloid plaques in their brain. Among the candidate tests jostling for ...

The company plans to begin using the instrument in its Burlington, North Carolina, lab in the first quarter of the year and ...

WETHERBY, England & CAMBRIDGE, England--(BUSINESS WIRE)--Avacta Group plc (AIM: AVCT), the developer of innovative cancer therapies and diagnostics based on its proprietary Affimer ® and pre|CISION™ ...

Ho, May 9, GNA – A team of McGill University researchers has developed a cost-effective, high-throughput technology for detecting nanoplastics and microplastics in the environment. These particles are ...

The Agilent 6470 Triple Quadrupole LC/MS system is at the forefront of robustness, reliability and accuracy, which makes it a perfect option for many applications, including peptide quantitation, food ...